Cite
APA Citation
Gambacorti‐Passerini, C., Nicolini, F. E., Larson, R. A., Aroldi, A., Fontana, D., Piazza, R., le Coutre, P., Antolini, L., & Assouline, S. (2022). caution in using second generation tyrosine kinase inhibitor, especially for first line therapy of chronic myeloid leukemia. American journal of hematology, 97(8), E296–E298. http://access.bl.uk/ark:/81055/vdc_100159169282.0x000043